Cabazitaxel prodrug nanoassemblies with branched chain modifications: Narrowing the gap between efficacy and safety

Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy

Bingjun Sun, Cong Luo, Yu Han et al. · Nano Letters · 2018 · 411 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +17

Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors

Alain C. Mita, Louis Denis, Eric K. Rowinsky et al. · Clinical Cancer Research · 2009 · 332 citations

Medicine, Oncology, Pharmacology +16

Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy

Bingjun Sun, Cong Luo, Xuanbo Zhang et al. · Nature Communications · 2019 · 321 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Disulfide Bond Bridge Insertion Turns Hydrophobic Anticancer Prodrugs into Self-Assembled Nanomedicines

Yongjun Wang, Dan Liŭ, Qing‐Chuan Zheng et al. · Nano Letters · 2014 · 250 citations · Full text

Medicine, Oncology, Pharmacology +17

Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy

Jing Gao, Bo Hou, Qiwen Zhu et al. · Nature Communications · 2022 · 202 citations · Full text

Pharmacy, Cancer Biology, Oncology +17